CytoDyn Financing Agreement (8-K, 11/03/2025)

CytoDyn Inc. secured a Standby Equity Purchase Agreement with Yorkville (YA II PN, Ltd.) for a committed facility of up to $30,000,000 over 36 months.

• Discretionary Funding: Company controls the timing and amount of sales, with no minimum usage obligation.
• Pricing: Shares sold at 98% of the lowest daily VWAP during a defined 3-day pricing period.
• Critical Limitation: Yorkville ownership is capped at 4.99% of outstanding shares.
• Conditions: Sales require an effective **Registration Statemen